Dr Michael Shi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dr michael shi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dr Michael Shi Today - Breaking & Trending Today

Sovleplenib Elicits Durable Responses in Primary Immune Thrombocytopenia

Sovleplenib provided a statistically significant and clinically meaningful increase in durable response rate over placebo in adult patients with primary immune thrombocytopenia in China. ....

Ren Chi Yang , Michael Shi , Institute Of Hematology , National Medical Products Administration Of China , Chinese Academy Of Medical Sciences , Blood Diseases Hospital , Chinese Academy , Medical Sciences , National Medical Products Administration , Dr Michael Shi , Primary Immune Thrombocytopenia , Hematologic Oncology , Phase 3 Eslim 01 Trial Nct05029635 ,

FDA Approval Sought for Fruquintinib in Refractory Metastatic Colorectal Cancer

A new drug application seeking the approval of fruquintinib for use in the treatment of patients with refractory metastatic colorectal cancer has been submitted to the FDA. ....

United States , Hutchinson China Meditech , North America , Asia Pacific , China Meditech , Patients With Refractory Metastatic Colorectal Cancer , Fresco 2 Trial , Fruquintinib Plus Best Supportive Care , Dr Michael Shi ,